Skip to main content

Esperion Therapeutics, Inc.

ESPRDelisted Jul 13, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001434868

Esperion Therapeutics, Inc. was delisted on Jul 13, 2026; its insiders filed their last Form 4 on Jul 13, 2026; 191 institutions reported holding it in 13F filings for Q2 2026, worth $646.8M in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q2 2022

Institutional positions in Esperion Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
137
+7 vs. Q1 2022
Shares held
55.3M
+3.57M (+6.9%) vs. Q1 2022
Total value
$352.1M
+$111.7M (+46.5%) vs. Q1 2022
New holders
24
42 more added
Sold out
17
42 more reduced

2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ESPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2022: 137 institutions
Q1 2021: 156 institutionsQ2 2021: 142 institutionsQ3 2021: 139 institutionsQ4 2021: 133 institutionsQ1 2022: 132 institutionsQ2 2022: 137 institutionsQ3 2022: 148 institutionsQ4 2022: 164 institutionsQ1 2023: 165 institutionsQ2 2023: 124 institutionsQ3 2023: 123 institutionsQ4 2023: 132 institutionsQ1 2024: 152 institutionsQ2 2024: 176 institutionsQ3 2024: 184 institutionsQ4 2024: 190 institutionsQ1 2025: 187 institutionsQ2 2025: 164 institutionsQ3 2025: 189 institutionsQ4 2025: 201 institutionsQ1 2026: 207 institutionsQ2 2026: 191 institutions
Value heldQ2 2022: $352.1M
Q1 2021: $805.3MQ2 2021: $599.4MQ3 2021: $299.4MQ4 2021: $268.0MQ1 2022: $241.2MQ2 2022: $352.1MQ3 2022: $425.5MQ4 2022: $457.6MQ1 2023: $129.1MQ2 2023: $103.6MQ3 2023: $75.9MQ4 2023: $215.3MQ1 2024: $336.2MQ2 2024: $304.2MQ3 2024: $214.3MQ4 2024: $277.9MQ1 2025: $171.5MQ2 2025: $96.6MQ3 2025: $286.1MQ4 2025: $559.6MQ1 2026: $479.3MQ2 2026: $646.8M
Institutions holding ESPR and their total value by quarter
QuarterHoldersValue
Q2 2026191$646.8M
Q1 2026207$479.3M
Q4 2025201$559.6M
Q3 2025189$286.1M
Q2 2025164$96.6M
Q1 2025187$171.5M
Q4 2024190$277.9M
Q3 2024184$214.3M
Q2 2024176$304.2M
Q1 2024152$336.2M
Q4 2023132$215.3M
Q3 2023123$75.9M
Q2 2023124$103.6M
Q1 2023165$129.1M
Q4 2022164$457.6M
Q3 2022148$425.5M
Q2 2022137$352.1M
Q1 2022132$241.2M
Q4 2021133$268.0M
Q3 2021139$299.4M
Q2 2021142$599.4M
Q1 2021156$805.3M

Institutions, Q2 2022

Shares, value and share of portfolio for each institution holding Esperion Therapeutics, Inc.; share changes are against Q1 2022.

Institutions holding ESPR in Q2 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Venture Visionary Partners LLC7,830$49.8K0.00%+7,830New
Legal & General Group Plc6,827$43.0K0.00%+82+1.2%Added
Wells Fargo & Company6,515$41.0K0.00%−4,338−40.0%Reduced
US Bancorp5,648$36.0K0.00%+1,156+25.7%Added
Citigroup Inc5,021$32.0K0.00%+1,577+45.8%Added
Ameritas Investment Partners, Inc.4,480$28.0K0.00%00.0%Unchanged
Nisa Investment Advisors, LLC3,800$24.0K0.00%00.0%Unchanged
Advisor Group Holdings, Inc.3,583$24.0K0.00%+62+1.8%Added
Aquatic Capital Management LLC3,600$23.0K0.01%+3,600New
Tower Research Capital LLC (TRC)2,946$19.0K0.00%−3,993−57.5%Reduced
Signaturefd, LLC2,895$18.0K0.00%+2,518+667.9%Added
Laurel Wealth Advisors LLC2,500$16.0K0.00%00.0%Unchanged
Captrust Financial Advisors2,312$15.0K0.00%+2,128+1,156.5%Added
Metropolitan Life Insurance Co2,357$15.0K0.00%−1,757−42.7%Reduced
Money Concepts Capital Corp2,012$13.0K0.00%−598−22.9%Reduced
Ahrens Investment Partners LLC2,000$13.0K0.01%00.0%Unchanged
Lindbrook Capital, LLC1,248$8.00K0.00%−426−25.4%Reduced
Royal Bank of Canada1,134$7.00K0.00%−3,189−73.8%Reduced
Quadrant Capital Group LLC669$4.00K0.00%+549+457.5%Added
Parkside Financial Bank & Trust400$3.00K0.00%00.0%Unchanged
Capital Advisors, Ltd. LLC467$3.00K0.00%+139+42.4%Added
Private Trust Co NA400$3.00K0.00%+400New
Benjamin F. Edwards & Company, Inc.375$2.00K0.00%00.0%Unchanged
CWM, LLC350$2.00K0.00%00.0%Unchanged
Ellevest, Inc.392$2.00K0.00%−42−9.7%Reduced
First Manhattan Co410$2.00K0.00%00.0%Unchanged
South State Corp.314$2.00K0.00%00.0%Unchanged
O'Dell Group, LLC261$2.00K0.00%00.0%Unchanged
Trust Co of Vermont300$2.00K0.00%+300New
Hall Laurie J Trustee200$1.00K0.00%00.0%Unchanged
Private Capital Group, LLC216$1.00K0.00%−69−24.2%Reduced
City State Bank200$1.00K0.00%00.0%Unchanged
Kistler-Tiffany Companies, LLC100$1.00K0.00%00.0%Unchanged
Rockefeller Capital Management L.P.200$1.00K0.00%00.0%Unchanged
Dark Forest Capital Management LP82$1.00K0.00%+82New
Elequin Capital LP36$00.00%−8−18.2%Reduced
Parallel Advisors, LLC35$00.00%+35New
Swedbank AB0$00.00%−217,000−100.0%Sold out
Pictet Asset Management SA0$00.00%−191,547−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−97,136−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−41,570−100.0%Sold out
AQR Capital Management LLC0$00.00%−41,059−100.0%Sold out
Bayesian Capital Management, LP0$00.00%−29,795−100.0%Sold out
XTX Topco Ltd0$00.00%−18,686−100.0%Sold out
Telemetry Investments, L.L.C.0$00.00%−17,500−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−15,598−100.0%Sold out
State of Wyoming0$00.00%−10,894−100.0%Sold out
Denali Advisors LLC0$00.00%−10,500−100.0%Sold out
NewSquare Capital LLC0$00.00%−1,600−100.0%Sold out
Bollard Group LLC0$00.00%−1,121−100.0%Sold out
Creative Financial Designs Inc0$00.00%−275−100.0%Sold out
Prospera Financial Services Inc0$00.00%−203−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−35−100.0%Sold out
AdvisorNet Financial, Inc0$00.00%−95−100.0%Sold out
Parametric Portfolio Associates LLC––––Not filed
Amalgamated Financial Corp.––––Not filed